{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:41:31Z","timestamp":1792550491677,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejps.2022.106365","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:18:15Z","timestamp":1671567495000},"page":"106365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["Pyrazole and pyrazoline derivatives as antimalarial agents: A key review"],"prefix":"10.1016","volume":"183","author":[{"given":"Lekkala","family":"Ravindar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aishah","family":"Hasbullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Rakesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-4290","authenticated-orcid":false,"given":"Nurul Izzaty","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106365_bib0001","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2009.10.023","article-title":"Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines","volume":"45","author":"Acharya","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1386207321666180213092911","article-title":"Pyrazole Schiff base hybrids as antimalarial agents: synthesis, in vitro screening and computational study","volume":"21","author":"Aggarwal","year":"2018","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.ejps.2022.106365_bib0003","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.bmcl.2011.03.037","article-title":"Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors","volume":"21","author":"Aher","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0004","first-page":"88","article-title":"Reaction of 5-amino-4-formyl-3-methyl(or phenyl)-1-phenyl-1H-pyrazoles with active methylene compounds: synthesis of fused heterocyclic rings","volume":"36","author":"Ahluwalia","year":"1997","journal-title":"Indian J. Chem., Sect. B"},{"key":"10.1016\/j.ejps.2022.106365_bib0005","first-page":"6","article-title":"Coumarin-pyrazoline derivatives: their one-pot microwave assisted synthesis and antimalarial activity","volume":"3","author":"Akhtar","year":"2017","journal-title":"J. Pharm. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0006","first-page":"318","article-title":"Microwave assisted synthesis of pyrazoline-coumarin hybrids and their in-vitro antimalarial evaluation","volume":"9","author":"Akhter","year":"2015","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0007","first-page":"1","article-title":"Design, synthesis and biological evaluation of novel furan & thiophene containing pyrazolyl pyrazolines as antimalarial agents","volume":"11","author":"Akolkar","year":"2020","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.ejps.2022.106365_bib0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bioorg.2016.10.001","article-title":"Rahisuddin. Design, synthesis, cytotoxicity, Hu Topoll\u03b1 inhibitory activity and molecular docking studies of pyrazole derivatives as anticancer agents","volume":"69","author":"Alam","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0009","article-title":"Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds","volume":"14","author":"Alidmat","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3077","article-title":"Public health challenges and prospects for malaria control and elimination","volume":"19","author":"Alonso","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2022.106365_bib0011","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/molecules24193601","article-title":"Combination Therapy Strategies for the Treatment of Malaria","volume":"24","author":"Alven","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2022.106365_bib0012","first-page":"1958","article-title":"Pharmaceutical importance of pyrazoline derivatives: a mini review","volume":"9","author":"Ardiansah","year":"2017","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0014","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/08927022.2021.1935926","article-title":"Theoretical studies of Thiazolyl-Pyrazoline derivatives as promising drugs against malaria by QSAR modeling combined with molecular docking and molecular dynamics simulation","volume":"47","author":"Arwansyah","year":"2021","journal-title":"Mol. Simul."},{"key":"10.1016\/j.ejps.2022.106365_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2016.09.073","article-title":"Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors","volume":"126","author":"Azeredo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0016","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1021\/jm00380a020","article-title":"3,4-Diphenyl-1H-pyrazole-1-propanamine antidepressants","volume":"28","author":"Bailey","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0017","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.arabjc.2015.04.011","article-title":"Molecular modeling, synthesis, and antimalarial potentials of curcumin analogues containing heterocyclic ring","volume":"12","author":"Balaji","year":"2015","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0018","first-page":"1767","article-title":"Evaluation of some 1H-pyrazole derivatives as a dual acting antimalarial and anti-leishmanial agents","volume":"27","author":"Bekhit","year":"2014","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","article-title":"New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents","volume":"94","author":"Bekhit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ardp.201100078","article-title":"Synthesis and biological evaluation of some pyrazole derivatives as antimalarial agents","volume":"345","author":"Bekhit","year":"2012","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0021","first-page":"6225","article-title":"Novel dual acting antimalarial antileishmanial agents derived from pyrazole moiety","volume":"12","author":"Bekhit","year":"2022","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejmech.2018.11.067","article-title":"Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents","volume":"163","author":"Bekhit","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0023","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1007\/s00044-013-0530-7","article-title":"Novel 2-pyrazoline derivatives as potential anticonvulsant agents","volume":"22","author":"Bhandari","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0024","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejmech.2007.11.005","article-title":"Bis-pyrazolines: synthesis, characterization and anti amoebic activity as inhibitors of growth of Entamoeba histolytica","volume":"44","author":"Bhat","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0025","first-page":"4113","article-title":"A review on recent development of pyrazoline as a pharmacologically active molecule","volume":"6","author":"Bhutani","year":"2015","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0026","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1475-2875-11-431","article-title":"Sustainable malaria control: transdisciplinary approaches for translational applications","volume":"11","author":"Birkholtz","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ejps.2022.106365_bib0027","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1570193X19666211220141622","article-title":"One-pot synthesis of pyrano[2,3-c] pyrazole derivatives via multicomponent reactions (MCRs) and their applications in medicinal chemistry","volume":"19","author":"Biswas","year":"2022","journal-title":"Mini Rev. Org. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0028","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1021\/jm201108k","article-title":"Novel orally active antimalarial thiazoles","volume":"54","author":"Cabrera","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900292","article-title":"Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases","volume":"353","author":"\u00c7elik","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejps.2022.106365_bib0030","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1016\/j.bmcl.2014.09.071","article-title":"Structure-activity relationship studies of antiplasmodial aminomethylthiazoles","volume":"24","author":"Cheuka","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0031","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1871524922666220301121811","article-title":"Pyrazole based furanone hybrids as novel antimalarial: a combined experimental, pharmacological and computational study","volume":"22","author":"Choudhary","year":"2022","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0032","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bmcl.2005.10.033","article-title":"Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues","volume":"16","author":"Cunico","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0033","first-page":"482","article-title":"Synthesis and antimalarial activity of substituted pyrazole derivatives","volume":"52","author":"Dominguez","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2022.106365_bib0034","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/biomedicines10051124","article-title":"A review of the recent development in the synthesis and biological evaluations of pyrazole derivatives","volume":"10","author":"Ebenezer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejps.2022.106365_bib0035","article-title":"Search for structurally diverse heterocyclic analogs as dual-acting antimalarial and antileishmanial agents: an overview","volume":"4","author":"Faheem","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0036","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12039-019-1646-1","article-title":"Recent developments in synthetic chemistry and biological activities of pyrazole derivatives","volume":"131","author":"Faisal","year":"2019","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0037","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.bmc.2006.03.021","article-title":"Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening","volume":"14","author":"Foloppe","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41375-020-0845-6","article-title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","volume":"35","author":"Garc\u00eda-Ca\u00f1averas","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ejps.2022.106365_bib0039","doi-asserted-by":"crossref","first-page":"22682","DOI":"10.1002\/jbt.22682","article-title":"In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5-triazine derivatives","volume":"35","author":"Gogoi","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejps.2022.106365_bib0040","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1016\/j.bmc.2007.06.004","article-title":"A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and anti-inflammatory analgesics","volume":"15","author":"Gokhan-Kelekci","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0041","doi-asserted-by":"crossref","first-page":"9931","DOI":"10.1016\/j.tet.2013.09.082","article-title":"Meglumine promoted one-pot, four-component synthesis of pyranopyrazole derivatives","volume":"69","author":"Guo","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejps.2022.106365_bib0042","first-page":"1","article-title":"Moleculardocking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment","volume":"10","author":"Hasan","year":"2015","journal-title":"Biol. Med."},{"key":"10.1016\/j.ejps.2022.106365_bib0043","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3390\/molecules18032683","article-title":"Synthesis, antibacterial and antifungal activity of some new pyrazoline and pyrazole derivatives","volume":"18","author":"Hassan","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2022.106365_bib0044","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmech.2014.07.103","article-title":"Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity","volume":"85","author":"Havrylyuk","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0045","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1021\/ol060570p","article-title":"1,3-diketones from acid chlorides and ketones: a rapid and general one pot synthesis of pyrazoles","volume":"8","author":"Heller","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0046","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.bmcl.2018.03.058","article-title":"Designing novel inhibitors against falcipain-2 of Plasmodium falciparum","volume":"28","author":"Himangini","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0047","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2013.06.049","article-title":"Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl) amino]chalcones and hydrazine as potential antitumor and antimalarial agents","volume":"67","author":"Insuasty","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0048","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2015.02.040","article-title":"An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents","volume":"93","author":"Insuasty","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0049","first-page":"114","article-title":"A review on pyrazole derivatives of pharmacological potential","volume":"3","author":"Jamwal","year":"2013","journal-title":"J. Pharm. BioSci."},{"key":"10.1016\/j.ejps.2022.106365_bib0050","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/14756360701442332","article-title":"Synthesis and characterization of biologically significant 5,5\u2032-(1,4-phenylene)bis(1-Nalkoxyphthalimido-3-aryl-2-pyrazoline) derivatives","volume":"23","author":"Jat","year":"2008","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0051","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmech.2015.10.047","article-title":"Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties","volume":"107","author":"Joshi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0052","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/jo051878h","article-title":"Aqueous N-heterocyclization of primary amines and hydrazines with dihalides: microwave-assisted syntheses of N-azacycloalkanes, isoindole, pyrazole, pyrazolidine, and phthalazine derivatives","volume":"71","author":"Ju","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0053","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejmech.2018.08.040","article-title":"A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery","volume":"158","author":"Kalaria","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0054","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1039\/c3nj01327h","article-title":"Synthesis, characterization and biological screening of novel 5-imidazopyrazole incorporated fused pyran motifs under microwave irradiation","volume":"38","author":"Kalaria","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0057","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.ejmech.2010.06.011","article-title":"New pyrazoline derivatives and their antidepressant activity","volume":"45","author":"Kaplanc\u0131kl\u0131","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0058","doi-asserted-by":"crossref","first-page":"41532","DOI":"10.1039\/C6RA01349J","article-title":"Design, Synthesis and characterization of fluoro substituted novel pyrazole nucleus clubbed with 1,3,4-oxadiazole scaffolds and their biological applications","volume":"6","author":"Karad","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2022.106365_bib0059","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejmech.2014.07.008","article-title":"Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening","volume":"84","author":"Karad","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0060","doi-asserted-by":"crossref","first-page":"16000","DOI":"10.1039\/C5RA00388A","article-title":"Green synthesis and pharmacological screening of polyhydroquinoline derivatives bearing fluorinated 5-aryloxypyrazole nucleus","volume":"5","author":"Karad","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2022.106365_bib0062","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2022.106365_bib0063","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1021\/jm960444z","article-title":"New potent antihyperglycemic agents in db\/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and \u2013pyrazolones","volume":"39","author":"Kees","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0064","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejmech.2016.04.077","article-title":"The therapeutic voyage of pyrazole and its analogs: a review","volume":"120","author":"Khan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0065","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1016\/j.bmc.2014.09.028","article-title":"Synthesis and evaluation of pyrazolines bearing benzothiazole as antiinflammatory agents","volume":"22","author":"Kharbanda","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0066","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bmcl.2011.10.059","article-title":"Synthesis, antitubercular evaluation and 3D-QSAR study of Nphenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives","volume":"22","author":"Khunt","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0067","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5267\/j.ccl.2013.07.002","article-title":"One-pot, four-component synthesis of pyrano[2,3-c]pyrazoles catalyzed by sodium benzoate in aqueous medium","volume":"2","author":"Kiyani","year":"2013","journal-title":"Curr. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0068","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7124\/bc.000A20","article-title":"Preliminary evaluation of thiazolidinone- and pyrazoline-related heterocyclic derivatives as potential antimalarial agents","volume":"36","author":"Kryshchyshyn-Dylevych","year":"2020","journal-title":"Biopolym. Cell."},{"key":"10.1016\/j.ejps.2022.106365_bib0069","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejmech.2014.11.059","article-title":"Recent advances in bioactive pyrazoles","volume":"97","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.082","article-title":"Pyrazole-pyrazoline as promising novel antimalarial agents: a mechanistic study","volume":"149","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0071","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13065-017-0344-7","article-title":"Design, synthesis, conformational and molecular docking study of some novel acyl hydrazone based molecular hybrids as antimalarial and antimicrobial agents","volume":"11","author":"Kumar","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejps.2022.106365_bib0072","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.sjbs.2015.07.005","article-title":"Antiinflammatory and antimicrobial activities of novel pyrazole analogues","volume":"23","author":"Kumar","year":"2016","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0073","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00397910500334561","article-title":"Synthesis and evaluation of substituted pyrazoles: potential antimalarials targeting the enoyl-ACP reductase of Plasmodium falciparum","volume":"36","author":"Kumar","year":"2006","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejps.2022.106365_bib0074","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/jm00370a020","article-title":"Studies on heterocyclic compounds. 6. Synthesis and analgesic and antiinflammatory activities of 3,4-dimethylpyrano[2,3-c]pyrazol-6-one derivatives","volume":"27","author":"Kuo","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0075","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1016\/j.bmcl.2010.07.056","article-title":"Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists","volume":"20","author":"Lange","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0076","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1016\/j.bmcl.2013.08.010","article-title":"Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): preparation and evaluation of pyrazole linked analogues","volume":"23","author":"Large","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0077","first-page":"23","article-title":"Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity","volume":"13","author":"Lohidashan","year":"2018","journal-title":"Bangl. J. Pharmacol."},{"key":"10.1016\/j.ejps.2022.106365_bib0078","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1016\/j.bmcl.2011.07.010","article-title":"Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents","volume":"21","author":"Lv","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0079","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1021\/acs.jmedchem.5b01605","article-title":"A novel pyrazolopyridine with in vivo activity in Plasmodium berghei- and Plasmodium falciparum-infected mouse models from structure-activity relationship studies around the core of recently identified antimalarial imidazopyridazines","volume":"58","author":"Manach","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0080","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1016\/j.bmcl.2012.06.055","article-title":"Eco-friendly synthesis and biological evaluation of substituted pyrano[2,3-c]pyrazoles","volume":"22","author":"Mandha","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0081","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bmcl.2009.10.106","article-title":"Synthesis, antimalarial activity, and cytotoxicity of 4-aminoquinoline-triazine conjugates","volume":"20","author":"Manohar","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0082","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00044-014-1188-5","article-title":"Synthesis, 3D-QSAR and docking studies of pyrimidine nitrile-pyrazoline: a novel class of hybrid antimalarial agents","volume":"24","author":"Marella","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0083","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/14756366.2014.958081","article-title":"Novel pyrazole-pyrazoline hybrids endowed with thioamide as antimalarial agents: their synthesis and 3D-QSAR studies","volume":"30","author":"Marella","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem"},{"key":"10.1016\/j.ejps.2022.106365_bib0084","doi-asserted-by":"crossref","first-page":"85350","DOI":"10.1039\/C5RA17185G","article-title":"Synthesis of 1,3,5-trisubstituted pyrazoline derivatives and their applications","volume":"5","author":"Mehta","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2022.106365_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0223-5234(96)88220-1","article-title":"Preparation, structural analysis and anticonvulsant activity of 3- and 5-aminopyrazole N-benzoyl derivatives","volume":"30","author":"Michon","year":"1995","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0086","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bmcl.2012.11.100","article-title":"Additional acetyl cholinesterase inhibitory property of diaryl pyrazoline derivatives","volume":"23","author":"Mishra","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0087","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.bmc.2007.12.054","article-title":"Synthesis and exploration of novel curcumin analogues as antimalarial agents","volume":"16","author":"Mishra","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0088","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.bmc.2017.02.025","article-title":"Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents","volume":"25","author":"Mishra","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0089","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jhet.700","article-title":"Synthesis, characterization, and in vitro biological studies of some novel pyran fused pyrimidone derivatives","volume":"49","author":"Mistry","year":"2012","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0090","series-title":"In silico approach for new antimalarial drug, 1st Asian Researchers Symposium","article-title":"Chalcone and its pyrazole derivatives as potential Plasmodium falciparum lactate dehydrogenase inhibitor","author":"Nasution","year":"2016"},{"key":"10.1016\/j.ejps.2022.106365_bib0091","doi-asserted-by":"crossref","first-page":"112666","DOI":"10.1016\/j.ejmech.2020.112666","article-title":"Recent advancements in the development of bioactive pyrazoline derivatives","volume":"205","author":"Nehra","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0092","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejmech.2014.04.046","article-title":"Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea\/thiourea derivatives as antihyperglycaemic agents and aldose reductase inhibitors","volume":"80","author":"Ovais","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0093","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00044-011-9619-z","article-title":"Antinociceptive activities of some triazole and pyrazoline moieties-bearing compounds","volume":"21","author":"\u00d6zkay","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0094","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.tetlet.2016.06.019","article-title":"N-arylation of nitrogen containing heterocycles with aryl halides using copper nanoparticle catalytic system","volume":"57","author":"Pai","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2016.07.055","article-title":"4, 5-Dihydrooxazole-pyrazoline hybrids: synthesis and their evaluation as potential antimalarial agents","volume":"123","author":"Pandey","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0096","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s42250-019-00096-5","article-title":"Development of antimicrobial, antimalarial and antitubercular compounds based on a quinolinepyrazole clubbed scaffold derived via Doebner reaction","volume":"3","author":"Pandya","year":"2020","journal-title":"Chem. Afr."},{"key":"10.1016\/j.ejps.2022.106365_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131605","article-title":"Microwave-assisted synthesis of pyrano[2,3-c]-pyrazole derivatives and their antimicrobial, antimalarial, antitubercular, and anticancer activities","volume":"1249","author":"Parikh","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2022.106365_bib0098","doi-asserted-by":"crossref","first-page":"27627","DOI":"10.1039\/D1RA03970A","article-title":"Coumarin-carbazole based functionalized pyrazolines: synthesis, characterization, anticancer investigation and molecular docking","volume":"11","author":"Patel","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2022.106365_bib0099","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1016\/j.bmcl.2012.05.063","article-title":"Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlrophenyl)-4-substituted pyrazole derivatives","volume":"22","author":"Pathak","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0100","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/molecules24224095","article-title":"The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines","volume":"24","author":"Pinheiro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2022.106365_bib0101","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1039\/C8NJ00670A","article-title":"Microwave assisted one-pot synthetic route to imidazo[1,2-a]pyrimidine derivatives of imidazo\/triazole clubbed pyrazole and their pharmacological screening","volume":"42","author":"Prasad","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review","volume":"193","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0103","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1385272826666220119110347","article-title":"An update on the synthesis and pharmacological properties of pyrazoles obtained from chalcone","volume":"26","author":"Queiroz","year":"2022","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0104","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jinorgbio.2011.09.021","article-title":"Platinum(II) and palladium(II) complexes with (N,N\u2032) and (C,N,N\u2032)- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities","volume":"105","author":"Quirante","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejps.2022.106365_bib0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ejmech.2014.12.023","article-title":"Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle","volume":"97","author":"Raffa","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102933","article-title":"Synthesis of thymol-based pyrazolines: an effort to perceive novel potent-antimalarials","volume":"88","author":"Raghuvanshi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0107","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jccs.201100194","article-title":"Pyrazolones as building blocks in heterocyclic synthesis: synthesis of new pyrazolopyran, pyrazolopyridazine and pyrazole derivatives of expected antifungicidal activity","volume":"59","author":"Ramiz","year":"2012","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.ejps.2022.106365_bib0108","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bmcl.2009.11.015","article-title":"Towards development of selective and reversible pyrazoline based MAO-inhibitors: synthesis, biological evaluation and docking studies","volume":"20","author":"Sahoo","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0109","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/(SICI)1097-461X(1996)60:8<1835::AID-QUA11>3.0.CO;2-Z","article-title":"A semiempirical study of pyrazole acylhydrazones as potential antimalarial agents","volume":"60","author":"Sant'anna","year":"1996","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0110","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1039\/c3ob42132e","article-title":"Catalytic regioselective Synthesis of pyrazole based pyrido[2,3-d]pyrimidine-diones and their biological evaluation","volume":"12","author":"Satasia","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0111","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/ph14111174","article-title":"Synthesis, molecular docking, and antimalarial activity of hybrid 4-aminoquinoline-pyrano[2,3-c]pyrazole derivatives","volume":"14","author":"Shamsuddin","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2022.106365_bib0112","first-page":"52","article-title":"Synthesis and molecular docking studies of pyrano[2,3-c] pyrazole-3-carboxylates as potential inhibitors of Plasmodium falciparum","volume":"22","author":"Shamsuddin","year":"2020","journal-title":"Malays. J. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0113","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jscs.2012.04.009","article-title":"Synthesis, characterization and anticancer studies of new steroidal oxadiazole, pyrrole and pyrazole derivatives","volume":"19","author":"Shamsuzzaman","year":"2015","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejps.2022.106365_bib0114","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1039\/C9MD00479C","article-title":"An epigrammatic status of the 'azole\u2019-based antimalarial drugs","volume":"11","author":"Sharmabc","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0115","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1016\/j.bmc.2016.07.049","article-title":"Design, synthesis and anti-P.falciparum activity of pyrazolopyridine-sulfonamide derivatives","volume":"24","author":"Silva","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0116","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00044-018-2199-4","article-title":"Synthesis and anti-Plasmodium falciparum evaluation of novel pyrazolopyrimidine derivatives","volume":"27","author":"Silveira","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejps.2022.106365_bib0117","first-page":"1","article-title":"Current study about pharmacological properties of pyrazole","volume":"11","author":"Singh","year":"2021","journal-title":"Int. J. Pharm. Erud."},{"key":"10.1016\/j.ejps.2022.106365_bib0118","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1747-0285.2010.01020.x","article-title":"Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents","volume":"76","author":"Sivakumar","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejps.2022.106365_bib0119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.22159\/ijpps.2016v8i11.12634","article-title":"A battle against AIDS: new pyrazole key to an older lock-reverse transcriptase","volume":"8","author":"Sony","year":"2016","journal-title":"Int. J. Pham. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/c2gc16425f","article-title":"Synthesis of novel fused heterocycleoxa-aza-phenanthrene and anthracene derivatives via sequential one-pot synthesis in aqueous micellar system","volume":"14","author":"Srivastava","year":"2012","journal-title":"Green Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102982","article-title":"Tetrahydro-1H,5H-pyrazolo [1,2-a] pyrazole-1-carboxylates as inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase","volume":"89","author":"Strasek","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0123","doi-asserted-by":"crossref","first-page":"121","DOI":"10.56808\/3027-7922.1979","article-title":"Synthesis and biological screening of some thienyl and phenyl pyrazoline derivatives as antimalarial agent","volume":"38","author":"Tuha","year":"2014","journal-title":"Thai J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0124","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","article-title":"Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum","volume":"5","author":"Vaidya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2022.106365_bib0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bioorg.2018.01.007","article-title":"Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents","volume":"77","author":"Verma","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102986","article-title":"Targeting malaria and leishmaniasis: synthesis and pharmacological evaluation of novel pyrazole 1,3,4-oxadiazole hybrids. Part II","volume":"89","author":"Verma","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0127","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2012.12.057","article-title":"New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents","volume":"62","author":"Vijesh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0128","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1016\/j.bmcl.2010.05.069","article-title":"Synthesis of novel \u03b1-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors","volume":"20","author":"Wanare","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106365_bib0129","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","article-title":"Structure-based discovery of an organic compound that binds Bcl-2-protien and induces apoptosis of tumor cell","volume":"97","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2022.106365_bib0130","series-title":"Pyrazolones, Pyrazolidones and Derivatives","first-page":"102","author":"Wiley","year":"1964"},{"key":"10.1016\/j.ejps.2022.106365_bib0131","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1021\/jm501987h","article-title":"Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities","volume":"58","author":"Witschel","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_bib0132","unstructured":"World malaria report 2018, World Health Organization, Geneva, 2018, p. 166."},{"key":"10.1016\/j.ejps.2022.106365_bib0133","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1016\/j.tet.2015.07.010","article-title":"Synthesis of \u03b1-ketols by functionalization of captodative alkenes and divergent preparation of heterocycles and natural products","volume":"71","author":"Z\u00e1rate-Z\u00e1rate","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejps.2022.106365_fur1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.22159\/ajpcr.2017.v10i12.22065","article-title":"Recent reports on pyrazole-based bioactive compounds as candidate for anticancer agents","volume":"12","author":"Ardiansah","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.ejps.2022.106365_fur2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2014.02.015","article-title":"Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives","volume":"78","author":"Kalaria","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106365_fur3","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1039\/c4nj00244j","article-title":"Synthesis, identification and in vitro biological evaluation of some novel 5-imidazopyrazole incorporated pyrazoline and isoxazoline derivatives","volume":"38","author":"Kalaria","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejps.2022.106365_fur4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2016.02.016","article-title":"Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: synthesis, antibacterial, antitubercular and antimalarial activities","volume":"112","author":"Karad","year":"2016","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722002500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722002500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:07:54Z","timestamp":1760530074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722002500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":133,"alternative-id":["S0928098722002500"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106365","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazole and pyrazoline derivatives as antimalarial agents: A key review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106365"}}